Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.

Burkholderia pseudomallei, the causative agent of melioidosis has been recognized by CDC as a category B select agent. Although substantial efforts have been made for development of vaccine molecules against the pathogen, significant hurdles still remain. With no licensed vaccines available and high...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Bhavani V Peddayelachagiri, Soumya Paul, Shivakiran S Makam, Radhika M Urs, Joseph J Kingston, Urmil Tuteja, Murali H Sripathy, Harsh V Batra
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2014
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9d37de987c79439891bf6b072a41b6be
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9d37de987c79439891bf6b072a41b6be
record_format dspace
spelling oai:doaj.org-article:9d37de987c79439891bf6b072a41b6be2021-11-18T08:28:56ZFunctional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.1932-620310.1371/journal.pone.0090930https://doaj.org/article/9d37de987c79439891bf6b072a41b6be2014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24614539/?tool=EBIhttps://doaj.org/toc/1932-6203Burkholderia pseudomallei, the causative agent of melioidosis has been recognized by CDC as a category B select agent. Although substantial efforts have been made for development of vaccine molecules against the pathogen, significant hurdles still remain. With no licensed vaccines available and high relapse rate of the disease, there is a pressing need for development of alternate protection strategies. Antibody-mediated passive protection is promising in this regard and our primary interest was to unravel this frontier of specific mAbs against Burkholderia pseudomallei infections, as functional characterization of antibodies is a pre-requisite to demonstrate them as protective molecules. To achieve this, we designed our study on in vitro-based approach and assessed two mAbs, namely BURK24 and BURK37, reactive with outer membrane proteins and lipopolysaccharide of the pathogen respectively, for their ability to manifest inhibitory effects on the pathogenesis mechanisms of B. pseudomallei including biofilm formation, invasion and induction of apoptosis. The experiments were performed using B. pseudomallei standard strain NCTC 10274 and a clinical isolate, B. pseudomallei 621 recovered from a septicemia patient with diabetic ailment. The growth kinetic studies of the pathogen in presence of various concentrations of each individual mAb revealed their anti-bacterial properties. Minimal inhibitory concentration and minimal bactericidal concentration of both the mAbs were determined by using standards of Clinical and Laboratory Standards Institute (CLSI) and experiments were performed using individual mAbs at their respective bacteriostatic concentration. As an outcome, both mAbs exhibited significant anti-Burkholderia pseudomallei properties. They limited the formation of biofilm by the bacterium and completely crippled its invasion into human alveolar adenocarcinoma epithelial cells. Also, the mAbs were appreciably successful in preventing the bacterium to induce apoptosis in A549 cells. The present study design revealed the protection attributes possessed by BURK24 and BURK37 that has to be further substantiated by additional in vivo studies.Bhavani V PeddayelachagiriSoumya PaulShivakiran S MakamRadhika M UrsJoseph J KingstonUrmil TutejaMurali H SripathyHarsh V BatraPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 3, p e90930 (2014)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Bhavani V Peddayelachagiri
Soumya Paul
Shivakiran S Makam
Radhika M Urs
Joseph J Kingston
Urmil Tuteja
Murali H Sripathy
Harsh V Batra
Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.
description Burkholderia pseudomallei, the causative agent of melioidosis has been recognized by CDC as a category B select agent. Although substantial efforts have been made for development of vaccine molecules against the pathogen, significant hurdles still remain. With no licensed vaccines available and high relapse rate of the disease, there is a pressing need for development of alternate protection strategies. Antibody-mediated passive protection is promising in this regard and our primary interest was to unravel this frontier of specific mAbs against Burkholderia pseudomallei infections, as functional characterization of antibodies is a pre-requisite to demonstrate them as protective molecules. To achieve this, we designed our study on in vitro-based approach and assessed two mAbs, namely BURK24 and BURK37, reactive with outer membrane proteins and lipopolysaccharide of the pathogen respectively, for their ability to manifest inhibitory effects on the pathogenesis mechanisms of B. pseudomallei including biofilm formation, invasion and induction of apoptosis. The experiments were performed using B. pseudomallei standard strain NCTC 10274 and a clinical isolate, B. pseudomallei 621 recovered from a septicemia patient with diabetic ailment. The growth kinetic studies of the pathogen in presence of various concentrations of each individual mAb revealed their anti-bacterial properties. Minimal inhibitory concentration and minimal bactericidal concentration of both the mAbs were determined by using standards of Clinical and Laboratory Standards Institute (CLSI) and experiments were performed using individual mAbs at their respective bacteriostatic concentration. As an outcome, both mAbs exhibited significant anti-Burkholderia pseudomallei properties. They limited the formation of biofilm by the bacterium and completely crippled its invasion into human alveolar adenocarcinoma epithelial cells. Also, the mAbs were appreciably successful in preventing the bacterium to induce apoptosis in A549 cells. The present study design revealed the protection attributes possessed by BURK24 and BURK37 that has to be further substantiated by additional in vivo studies.
format article
author Bhavani V Peddayelachagiri
Soumya Paul
Shivakiran S Makam
Radhika M Urs
Joseph J Kingston
Urmil Tuteja
Murali H Sripathy
Harsh V Batra
author_facet Bhavani V Peddayelachagiri
Soumya Paul
Shivakiran S Makam
Radhika M Urs
Joseph J Kingston
Urmil Tuteja
Murali H Sripathy
Harsh V Batra
author_sort Bhavani V Peddayelachagiri
title Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.
title_short Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.
title_full Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.
title_fullStr Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.
title_full_unstemmed Functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies BURK24 and BURK37 against Burkholderia pseudomallei.
title_sort functional characterization and evaluation of in vitro protective efficacy of murine monoclonal antibodies burk24 and burk37 against burkholderia pseudomallei.
publisher Public Library of Science (PLoS)
publishDate 2014
url https://doaj.org/article/9d37de987c79439891bf6b072a41b6be
work_keys_str_mv AT bhavanivpeddayelachagiri functionalcharacterizationandevaluationofinvitroprotectiveefficacyofmurinemonoclonalantibodiesburk24andburk37againstburkholderiapseudomallei
AT soumyapaul functionalcharacterizationandevaluationofinvitroprotectiveefficacyofmurinemonoclonalantibodiesburk24andburk37againstburkholderiapseudomallei
AT shivakiransmakam functionalcharacterizationandevaluationofinvitroprotectiveefficacyofmurinemonoclonalantibodiesburk24andburk37againstburkholderiapseudomallei
AT radhikamurs functionalcharacterizationandevaluationofinvitroprotectiveefficacyofmurinemonoclonalantibodiesburk24andburk37againstburkholderiapseudomallei
AT josephjkingston functionalcharacterizationandevaluationofinvitroprotectiveefficacyofmurinemonoclonalantibodiesburk24andburk37againstburkholderiapseudomallei
AT urmiltuteja functionalcharacterizationandevaluationofinvitroprotectiveefficacyofmurinemonoclonalantibodiesburk24andburk37againstburkholderiapseudomallei
AT muralihsripathy functionalcharacterizationandevaluationofinvitroprotectiveefficacyofmurinemonoclonalantibodiesburk24andburk37againstburkholderiapseudomallei
AT harshvbatra functionalcharacterizationandevaluationofinvitroprotectiveefficacyofmurinemonoclonalantibodiesburk24andburk37againstburkholderiapseudomallei
_version_ 1718421757125197824